Related Experiment Videos
Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study
T W Weiss1, E S Siris, E Barrett-Connor
1US Outcomes Research, Merck & Co. Inc., PO Box 4 (WP39-166), West Point, PA 19486, USA. thomas_weiss@merck.com
Unlabelled:
This study investigated osteoporosis management trends from 1998 to 2006 among 808 primary care physicians involved in the US-based NORA (National Osteoporosis Risk Assessment) study. These results suggest some significant improvements in osteoporosis management over the past eight years.
Introduction:
The purpose of this study was to investigate osteoporosis management trends among a large cohort of primary care physicians (PCPs) involved in the US-based NORA (National Osteoporosis Risk Assessment) study.
Methods:
In 2006, we undertook a resurvey of the 2,836 NORA PCPs who completed a baseline survey in 1998. Of the 2,199 PCPs for whom we had current contact information and who were still practicing, we collected usable surveys from 808 (37% response rate).
Results:
From 1998 to 2006, more than double the percentage of NORA PCPs reported using BMDs "often" (35% vs. 87%). There was a doubling of the percentage of NORA PCPs who reported that a T-score of < or = -2.5 was the threshold indicating the presence of osteoporosis (34% vs. 67%). The percentage of NORA PCPs who reported using bone turnover markers to screen, diagnosis, or monitor osteoporosis almost tripled (19% vs. 55%). The percentage of patients prescribed or recommended hormone therapy dropped sixfold (67% to 11%), and the percentage of patients prescribed bisphosphonates increased fourfold from 15% to 59%.
Conclusion:
These results suggest some significant improvements in osteoporosis management over the past eight years.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Drug Dosing: Obese Patients
Angina V: Nursing Management
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Angina III: Clinical Manifestations and Assessment
Hypertension IV: Drug Therapy and Lifestyle Modifications